nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—AR—scrotum—Crohn's disease	0.0961	0.483	CbGeAlD
Bicalutamide—AR—penis—Crohn's disease	0.0434	0.218	CbGeAlD
Bicalutamide—Enzalutamide—ALB—Crohn's disease	0.00886	1	CrCbGaD
Bicalutamide—AR—epithelium—Crohn's disease	0.00761	0.0382	CbGeAlD
Bicalutamide—AR—smooth muscle tissue—Crohn's disease	0.00734	0.0368	CbGeAlD
Bicalutamide—Hepatotoxicity—Azathioprine—Crohn's disease	0.00731	0.00923	CcSEcCtD
Bicalutamide—Interstitial lung disease—Mesalazine—Crohn's disease	0.00726	0.00917	CcSEcCtD
Bicalutamide—Lung disorder—Mesalazine—Crohn's disease	0.00726	0.00917	CcSEcCtD
Bicalutamide—AR—skin of body—Crohn's disease	0.00724	0.0364	CbGeAlD
Bicalutamide—Pleural effusion—Mesalazine—Crohn's disease	0.00671	0.00848	CcSEcCtD
Bicalutamide—Hepatotoxicity—Mesalazine—Crohn's disease	0.00666	0.00841	CcSEcCtD
Bicalutamide—Neoplasm malignant—Azathioprine—Crohn's disease	0.00661	0.00835	CcSEcCtD
Bicalutamide—AR—mammalian vulva—Crohn's disease	0.0066	0.0332	CbGeAlD
Bicalutamide—Breast disorder—Mercaptopurine—Crohn's disease	0.00621	0.00785	CcSEcCtD
Bicalutamide—Blood disorder—Mesalazine—Crohn's disease	0.00616	0.00777	CcSEcCtD
Bicalutamide—Tenderness—Mesalazine—Crohn's disease	0.00589	0.00744	CcSEcCtD
Bicalutamide—Breast pain—Mesalazine—Crohn's disease	0.00589	0.00744	CcSEcCtD
Bicalutamide—AR—lymphoid tissue—Crohn's disease	0.00586	0.0294	CbGeAlD
Bicalutamide—AR—digestive system—Crohn's disease	0.00579	0.0291	CbGeAlD
Bicalutamide—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00573	0.00724	CcSEcCtD
Bicalutamide—Bone disorder—Mesalazine—Crohn's disease	0.00569	0.00719	CcSEcCtD
Bicalutamide—Rectal haemorrhage—Mesalazine—Crohn's disease	0.00569	0.00719	CcSEcCtD
Bicalutamide—Cough increased—Mesalazine—Crohn's disease	0.00562	0.00709	CcSEcCtD
Bicalutamide—Gout—Mesalazine—Crohn's disease	0.00551	0.00695	CcSEcCtD
Bicalutamide—Blood bilirubin increased—Mesalazine—Crohn's disease	0.00544	0.00686	CcSEcCtD
Bicalutamide—CYP2C19—digestive system—Crohn's disease	0.00537	0.027	CbGeAlD
Bicalutamide—Neck pain—Mesalazine—Crohn's disease	0.0052	0.00657	CcSEcCtD
Bicalutamide—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.00514	0.00649	CcSEcCtD
Bicalutamide—Neoplasm—Azathioprine—Crohn's disease	0.0051	0.00644	CcSEcCtD
Bicalutamide—Melaena—Mesalazine—Crohn's disease	0.00502	0.00634	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00501	0.00633	CcSEcCtD
Bicalutamide—Influenza like illness—Mesalazine—Crohn's disease	0.00499	0.0063	CcSEcCtD
Bicalutamide—Blood urea increased—Mesalazine—Crohn's disease	0.00485	0.00613	CcSEcCtD
Bicalutamide—Neuropathy—Mesalazine—Crohn's disease	0.00483	0.00609	CcSEcCtD
Bicalutamide—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00472	0.00596	CcSEcCtD
Bicalutamide—Multiple fractures—Prednisone—Crohn's disease	0.00468	0.00591	CcSEcCtD
Bicalutamide—Hirsutism—Prednisone—Crohn's disease	0.00468	0.00591	CcSEcCtD
Bicalutamide—Fracture—Prednisone—Crohn's disease	0.00468	0.00591	CcSEcCtD
Bicalutamide—Ecchymosis—Mesalazine—Crohn's disease	0.00465	0.00587	CcSEcCtD
Bicalutamide—Hepatic failure—Azathioprine—Crohn's disease	0.00456	0.00576	CcSEcCtD
Bicalutamide—Febrile neutropenia—Prednisone—Crohn's disease	0.00452	0.00571	CcSEcCtD
Bicalutamide—Hypertonia—Mesalazine—Crohn's disease	0.00451	0.00569	CcSEcCtD
Bicalutamide—Immune system disorder—Mercaptopurine—Crohn's disease	0.0043	0.00543	CcSEcCtD
Bicalutamide—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.00429	0.00542	CcSEcCtD
Bicalutamide—Alopecia—Mercaptopurine—Crohn's disease	0.0042	0.00531	CcSEcCtD
Bicalutamide—CYP2C9—digestive system—Crohn's disease	0.00416	0.0209	CbGeAlD
Bicalutamide—Hepatic failure—Mesalazine—Crohn's disease	0.00415	0.00524	CcSEcCtD
Bicalutamide—Malnutrition—Mercaptopurine—Crohn's disease	0.00414	0.00523	CcSEcCtD
Bicalutamide—Libido decreased—Mesalazine—Crohn's disease	0.00402	0.00508	CcSEcCtD
Bicalutamide—Atrial fibrillation—Mesalazine—Crohn's disease	0.00394	0.00497	CcSEcCtD
Bicalutamide—Arthritis—Mesalazine—Crohn's disease	0.00384	0.00485	CcSEcCtD
Bicalutamide—Anaemia—Mercaptopurine—Crohn's disease	0.00383	0.00483	CcSEcCtD
Bicalutamide—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.0037	0.00467	CcSEcCtD
Bicalutamide—Face oedema—Mesalazine—Crohn's disease	0.0036	0.00455	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0035	0.00442	CcSEcCtD
Bicalutamide—Blood creatinine increased—Mesalazine—Crohn's disease	0.0035	0.00441	CcSEcCtD
Bicalutamide—Liver function test abnormal—Mesalazine—Crohn's disease	0.00345	0.00435	CcSEcCtD
Bicalutamide—Dry skin—Mesalazine—Crohn's disease	0.00342	0.00432	CcSEcCtD
Bicalutamide—Oedema—Mercaptopurine—Crohn's disease	0.00338	0.00427	CcSEcCtD
Bicalutamide—Breast disorder—Mesalazine—Crohn's disease	0.00337	0.00426	CcSEcCtD
Bicalutamide—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00336	0.00424	CcSEcCtD
Bicalutamide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00331	0.00418	CcSEcCtD
Bicalutamide—AR—lymph node—Crohn's disease	0.00331	0.0166	CbGeAlD
Bicalutamide—Gastritis—Mesalazine—Crohn's disease	0.0033	0.00417	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00329	0.00416	CcSEcCtD
Bicalutamide—Skin disorder—Mercaptopurine—Crohn's disease	0.00328	0.00414	CcSEcCtD
Bicalutamide—Asthma—Mesalazine—Crohn's disease	0.00323	0.00407	CcSEcCtD
Bicalutamide—Influenza—Mesalazine—Crohn's disease	0.00323	0.00407	CcSEcCtD
Bicalutamide—Dysphagia—Mesalazine—Crohn's disease	0.00323	0.00407	CcSEcCtD
Bicalutamide—Anorexia—Mercaptopurine—Crohn's disease	0.00322	0.00407	CcSEcCtD
Bicalutamide—Eosinophilia—Mesalazine—Crohn's disease	0.00319	0.00403	CcSEcCtD
Bicalutamide—Pneumonia—Azathioprine—Crohn's disease	0.00318	0.00401	CcSEcCtD
Bicalutamide—CYP3A4—digestive system—Crohn's disease	0.00317	0.0159	CbGeAlD
Bicalutamide—Angina pectoris—Mesalazine—Crohn's disease	0.00314	0.00397	CcSEcCtD
Bicalutamide—CYP2D6—digestive system—Crohn's disease	0.00312	0.0157	CbGeAlD
Bicalutamide—Bronchitis—Mesalazine—Crohn's disease	0.0031	0.00392	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00308	0.00389	CcSEcCtD
Bicalutamide—Dysuria—Mesalazine—Crohn's disease	0.00302	0.00381	CcSEcCtD
Bicalutamide—Neutropenia—Mesalazine—Crohn's disease	0.00302	0.00381	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00299	0.00377	CcSEcCtD
Bicalutamide—Pollakiuria—Mesalazine—Crohn's disease	0.00298	0.00376	CcSEcCtD
Bicalutamide—Decreased appetite—Mercaptopurine—Crohn's disease	0.00294	0.00371	CcSEcCtD
Bicalutamide—Weight increased—Mesalazine—Crohn's disease	0.00294	0.00371	CcSEcCtD
Bicalutamide—Weight decreased—Mesalazine—Crohn's disease	0.00292	0.00368	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00292	0.00368	CcSEcCtD
Bicalutamide—Pneumonia—Mesalazine—Crohn's disease	0.00289	0.00365	CcSEcCtD
Bicalutamide—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00288	0.00363	CcSEcCtD
Bicalutamide—Depression—Mesalazine—Crohn's disease	0.00287	0.00362	CcSEcCtD
Bicalutamide—Cataract—Prednisone—Crohn's disease	0.00286	0.00361	CcSEcCtD
Bicalutamide—Haemoglobin—Azathioprine—Crohn's disease	0.00285	0.0036	CcSEcCtD
Bicalutamide—Haemorrhage—Azathioprine—Crohn's disease	0.00283	0.00358	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00282	0.00356	CcSEcCtD
Bicalutamide—Jaundice—Mesalazine—Crohn's disease	0.0028	0.00354	CcSEcCtD
Bicalutamide—Conjunctivitis—Mesalazine—Crohn's disease	0.0028	0.00353	CcSEcCtD
Bicalutamide—Urinary tract infection—Mesalazine—Crohn's disease	0.0028	0.00353	CcSEcCtD
Bicalutamide—Sweating—Mesalazine—Crohn's disease	0.00276	0.00348	CcSEcCtD
Bicalutamide—Haematuria—Mesalazine—Crohn's disease	0.00274	0.00346	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00272	0.00343	CcSEcCtD
Bicalutamide—Epistaxis—Mesalazine—Crohn's disease	0.00271	0.00342	CcSEcCtD
Bicalutamide—Sinusitis—Mesalazine—Crohn's disease	0.0027	0.00341	CcSEcCtD
Bicalutamide—Body temperature increased—Mercaptopurine—Crohn's disease	0.00267	0.00337	CcSEcCtD
Bicalutamide—Haemoglobin—Mesalazine—Crohn's disease	0.00259	0.00328	CcSEcCtD
Bicalutamide—Rhinitis—Mesalazine—Crohn's disease	0.00259	0.00327	CcSEcCtD
Bicalutamide—Haemorrhage—Mesalazine—Crohn's disease	0.00258	0.00326	CcSEcCtD
Bicalutamide—Pharyngitis—Mesalazine—Crohn's disease	0.00256	0.00324	CcSEcCtD
Bicalutamide—Immune system disorder—Azathioprine—Crohn's disease	0.00256	0.00323	CcSEcCtD
Bicalutamide—Mediastinal disorder—Azathioprine—Crohn's disease	0.00255	0.00323	CcSEcCtD
Bicalutamide—Neuropathy—Prednisone—Crohn's disease	0.00255	0.00322	CcSEcCtD
Bicalutamide—Urinary tract disorder—Mesalazine—Crohn's disease	0.00255	0.00322	CcSEcCtD
Bicalutamide—Oedema peripheral—Mesalazine—Crohn's disease	0.00254	0.00321	CcSEcCtD
Bicalutamide—Chills—Azathioprine—Crohn's disease	0.00254	0.00321	CcSEcCtD
Bicalutamide—Arrhythmia—Azathioprine—Crohn's disease	0.00253	0.0032	CcSEcCtD
Bicalutamide—Urethral disorder—Mesalazine—Crohn's disease	0.00253	0.0032	CcSEcCtD
Bicalutamide—Alopecia—Azathioprine—Crohn's disease	0.0025	0.00316	CcSEcCtD
Bicalutamide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00249	0.00314	CcSEcCtD
Bicalutamide—Ecchymosis—Prednisone—Crohn's disease	0.00246	0.00311	CcSEcCtD
Bicalutamide—Cardiac disorder—Mesalazine—Crohn's disease	0.0024	0.00303	CcSEcCtD
Bicalutamide—Sepsis—Prednisone—Crohn's disease	0.00236	0.00298	CcSEcCtD
Bicalutamide—Angiopathy—Mesalazine—Crohn's disease	0.00234	0.00296	CcSEcCtD
Bicalutamide—Immune system disorder—Mesalazine—Crohn's disease	0.00233	0.00294	CcSEcCtD
Bicalutamide—Mediastinal disorder—Mesalazine—Crohn's disease	0.00233	0.00294	CcSEcCtD
Bicalutamide—Chills—Mesalazine—Crohn's disease	0.00232	0.00292	CcSEcCtD
Bicalutamide—Diarrhoea—Mercaptopurine—Crohn's disease	0.00231	0.00292	CcSEcCtD
Bicalutamide—Alopecia—Mesalazine—Crohn's disease	0.00228	0.00288	CcSEcCtD
Bicalutamide—Thrombophlebitis—Prednisone—Crohn's disease	0.00228	0.00288	CcSEcCtD
Bicalutamide—Anaemia—Azathioprine—Crohn's disease	0.00228	0.00288	CcSEcCtD
Bicalutamide—Diabetes mellitus—Prednisone—Crohn's disease	0.00227	0.00287	CcSEcCtD
Bicalutamide—Mental disorder—Mesalazine—Crohn's disease	0.00226	0.00286	CcSEcCtD
Bicalutamide—Flatulence—Mesalazine—Crohn's disease	0.00221	0.0028	CcSEcCtD
Bicalutamide—Tension—Mesalazine—Crohn's disease	0.00221	0.00278	CcSEcCtD
Bicalutamide—Nervousness—Mesalazine—Crohn's disease	0.00218	0.00276	CcSEcCtD
Bicalutamide—Cardiac failure congestive—Prednisone—Crohn's disease	0.00218	0.00275	CcSEcCtD
Bicalutamide—Back pain—Mesalazine—Crohn's disease	0.00217	0.00274	CcSEcCtD
Bicalutamide—Muscle spasms—Mesalazine—Crohn's disease	0.00216	0.00273	CcSEcCtD
Bicalutamide—Vomiting—Mercaptopurine—Crohn's disease	0.00215	0.00271	CcSEcCtD
Bicalutamide—Rash—Mercaptopurine—Crohn's disease	0.00213	0.00269	CcSEcCtD
Bicalutamide—Dermatitis—Mercaptopurine—Crohn's disease	0.00213	0.00269	CcSEcCtD
Bicalutamide—Myalgia—Azathioprine—Crohn's disease	0.0021	0.00265	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00209	0.00263	CcSEcCtD
Bicalutamide—Anaemia—Mesalazine—Crohn's disease	0.00208	0.00262	CcSEcCtD
Bicalutamide—Angioedema—Mesalazine—Crohn's disease	0.00205	0.00259	CcSEcCtD
Bicalutamide—Cardiac failure—Prednisone—Crohn's disease	0.00202	0.00255	CcSEcCtD
Bicalutamide—Syncope—Mesalazine—Crohn's disease	0.00202	0.00254	CcSEcCtD
Bicalutamide—Nausea—Mercaptopurine—Crohn's disease	0.00201	0.00253	CcSEcCtD
Bicalutamide—Infection—Azathioprine—Crohn's disease	0.002	0.00253	CcSEcCtD
Bicalutamide—Loss of consciousness—Mesalazine—Crohn's disease	0.00198	0.00249	CcSEcCtD
Bicalutamide—Thrombocytopenia—Azathioprine—Crohn's disease	0.00197	0.00249	CcSEcCtD
Bicalutamide—Cough—Mesalazine—Crohn's disease	0.00196	0.00248	CcSEcCtD
Bicalutamide—Skin disorder—Azathioprine—Crohn's disease	0.00196	0.00247	CcSEcCtD
Bicalutamide—Hypertension—Mesalazine—Crohn's disease	0.00194	0.00245	CcSEcCtD
Bicalutamide—Chest pain—Mesalazine—Crohn's disease	0.00191	0.00242	CcSEcCtD
Bicalutamide—Myalgia—Mesalazine—Crohn's disease	0.00191	0.00242	CcSEcCtD
Bicalutamide—Anxiety—Mesalazine—Crohn's disease	0.00191	0.00241	CcSEcCtD
Bicalutamide—Face oedema—Prednisone—Crohn's disease	0.00191	0.00241	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.0019	0.0024	CcSEcCtD
Bicalutamide—Cardiac arrest—Prednisone—Crohn's disease	0.00188	0.00237	CcSEcCtD
Bicalutamide—Dry mouth—Mesalazine—Crohn's disease	0.00187	0.00236	CcSEcCtD
Bicalutamide—Confusional state—Mesalazine—Crohn's disease	0.00185	0.00234	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00183	0.00232	CcSEcCtD
Bicalutamide—Oedema—Mesalazine—Crohn's disease	0.00183	0.00232	CcSEcCtD
Bicalutamide—Infection—Mesalazine—Crohn's disease	0.00182	0.0023	CcSEcCtD
Bicalutamide—Dry skin—Prednisone—Crohn's disease	0.00181	0.00229	CcSEcCtD
Bicalutamide—Shock—Mesalazine—Crohn's disease	0.0018	0.00228	CcSEcCtD
Bicalutamide—Nervous system disorder—Mesalazine—Crohn's disease	0.0018	0.00227	CcSEcCtD
Bicalutamide—Thrombocytopenia—Mesalazine—Crohn's disease	0.0018	0.00227	CcSEcCtD
Bicalutamide—Skin disorder—Mesalazine—Crohn's disease	0.00178	0.00225	CcSEcCtD
Bicalutamide—Hyperhidrosis—Mesalazine—Crohn's disease	0.00177	0.00224	CcSEcCtD
Bicalutamide—Anorexia—Mesalazine—Crohn's disease	0.00175	0.00221	CcSEcCtD
Bicalutamide—Muscular weakness—Prednisone—Crohn's disease	0.00174	0.0022	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00174	0.0022	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00174	0.0022	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00167	0.00211	CcSEcCtD
Bicalutamide—Feeling abnormal—Azathioprine—Crohn's disease	0.00166	0.0021	CcSEcCtD
Bicalutamide—Insomnia—Mesalazine—Crohn's disease	0.00166	0.00209	CcSEcCtD
Bicalutamide—Paraesthesia—Mesalazine—Crohn's disease	0.00165	0.00208	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00165	0.00208	CcSEcCtD
Bicalutamide—Dyspnoea—Mesalazine—Crohn's disease	0.00164	0.00206	CcSEcCtD
Bicalutamide—Somnolence—Mesalazine—Crohn's disease	0.00163	0.00206	CcSEcCtD
Bicalutamide—Dyspepsia—Mesalazine—Crohn's disease	0.00161	0.00204	CcSEcCtD
Bicalutamide—Neutropenia—Prednisone—Crohn's disease	0.0016	0.00201	CcSEcCtD
Bicalutamide—Decreased appetite—Mesalazine—Crohn's disease	0.00159	0.00201	CcSEcCtD
Bicalutamide—Abdominal pain—Azathioprine—Crohn's disease	0.00159	0.00201	CcSEcCtD
Bicalutamide—Body temperature increased—Azathioprine—Crohn's disease	0.00159	0.00201	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00158	0.002	CcSEcCtD
Bicalutamide—Fatigue—Mesalazine—Crohn's disease	0.00158	0.002	CcSEcCtD
Bicalutamide—Erectile dysfunction—Prednisone—Crohn's disease	0.00157	0.00198	CcSEcCtD
Bicalutamide—Pain—Mesalazine—Crohn's disease	0.00157	0.00198	CcSEcCtD
Bicalutamide—Constipation—Mesalazine—Crohn's disease	0.00157	0.00198	CcSEcCtD
Bicalutamide—Weight increased—Prednisone—Crohn's disease	0.00155	0.00196	CcSEcCtD
Bicalutamide—Weight decreased—Prednisone—Crohn's disease	0.00154	0.00195	CcSEcCtD
Bicalutamide—Hyperglycaemia—Prednisone—Crohn's disease	0.00154	0.00194	CcSEcCtD
Bicalutamide—Depression—Prednisone—Crohn's disease	0.00152	0.00192	CcSEcCtD
Bicalutamide—Feeling abnormal—Mesalazine—Crohn's disease	0.00151	0.00191	CcSEcCtD
Bicalutamide—Acute coronary syndrome—Prednisone—Crohn's disease	0.0015	0.00189	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.0015	0.00189	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Prednisone—Crohn's disease	0.00149	0.00188	CcSEcCtD
Bicalutamide—Myocardial infarction—Prednisone—Crohn's disease	0.00149	0.00188	CcSEcCtD
Bicalutamide—Hypersensitivity—Azathioprine—Crohn's disease	0.00148	0.00187	CcSEcCtD
Bicalutamide—Urticaria—Mesalazine—Crohn's disease	0.00146	0.00184	CcSEcCtD
Bicalutamide—Abdominal pain—Mesalazine—Crohn's disease	0.00145	0.00183	CcSEcCtD
Bicalutamide—Body temperature increased—Mesalazine—Crohn's disease	0.00145	0.00183	CcSEcCtD
Bicalutamide—Bradycardia—Prednisone—Crohn's disease	0.00139	0.00176	CcSEcCtD
Bicalutamide—Diarrhoea—Azathioprine—Crohn's disease	0.00138	0.00174	CcSEcCtD
Bicalutamide—Haemoglobin—Prednisone—Crohn's disease	0.00137	0.00173	CcSEcCtD
Bicalutamide—Haemorrhage—Prednisone—Crohn's disease	0.00137	0.00172	CcSEcCtD
Bicalutamide—Hypersensitivity—Mesalazine—Crohn's disease	0.00135	0.00171	CcSEcCtD
Bicalutamide—Dizziness—Azathioprine—Crohn's disease	0.00133	0.00168	CcSEcCtD
Bicalutamide—Asthenia—Mesalazine—Crohn's disease	0.00132	0.00166	CcSEcCtD
Bicalutamide—Pruritus—Mesalazine—Crohn's disease	0.0013	0.00164	CcSEcCtD
Bicalutamide—Vomiting—Azathioprine—Crohn's disease	0.00128	0.00162	CcSEcCtD
Bicalutamide—Rash—Azathioprine—Crohn's disease	0.00127	0.0016	CcSEcCtD
Bicalutamide—Dermatitis—Azathioprine—Crohn's disease	0.00127	0.0016	CcSEcCtD
Bicalutamide—Headache—Azathioprine—Crohn's disease	0.00126	0.00159	CcSEcCtD
Bicalutamide—Diarrhoea—Mesalazine—Crohn's disease	0.00125	0.00158	CcSEcCtD
Bicalutamide—Angiopathy—Prednisone—Crohn's disease	0.00124	0.00156	CcSEcCtD
Bicalutamide—Immune system disorder—Prednisone—Crohn's disease	0.00123	0.00156	CcSEcCtD
Bicalutamide—Arrhythmia—Prednisone—Crohn's disease	0.00122	0.00154	CcSEcCtD
Bicalutamide—Dizziness—Mesalazine—Crohn's disease	0.00121	0.00153	CcSEcCtD
Bicalutamide—Alopecia—Prednisone—Crohn's disease	0.00121	0.00152	CcSEcCtD
Bicalutamide—Mental disorder—Prednisone—Crohn's disease	0.0012	0.00151	CcSEcCtD
Bicalutamide—Nausea—Azathioprine—Crohn's disease	0.0012	0.00151	CcSEcCtD
Bicalutamide—Malnutrition—Prednisone—Crohn's disease	0.00119	0.0015	CcSEcCtD
Bicalutamide—Vomiting—Mesalazine—Crohn's disease	0.00117	0.00147	CcSEcCtD
Bicalutamide—Rash—Mesalazine—Crohn's disease	0.00116	0.00146	CcSEcCtD
Bicalutamide—Dermatitis—Mesalazine—Crohn's disease	0.00116	0.00146	CcSEcCtD
Bicalutamide—Headache—Mesalazine—Crohn's disease	0.00115	0.00145	CcSEcCtD
Bicalutamide—Anaemia—Prednisone—Crohn's disease	0.0011	0.00139	CcSEcCtD
Bicalutamide—Nausea—Mesalazine—Crohn's disease	0.00109	0.00138	CcSEcCtD
Bicalutamide—Angioedema—Prednisone—Crohn's disease	0.00109	0.00137	CcSEcCtD
Bicalutamide—Syncope—Prednisone—Crohn's disease	0.00107	0.00135	CcSEcCtD
Bicalutamide—Loss of consciousness—Prednisone—Crohn's disease	0.00105	0.00132	CcSEcCtD
Bicalutamide—Hypertension—Prednisone—Crohn's disease	0.00103	0.0013	CcSEcCtD
Bicalutamide—Myalgia—Prednisone—Crohn's disease	0.00101	0.00128	CcSEcCtD
Bicalutamide—Anxiety—Prednisone—Crohn's disease	0.00101	0.00127	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00101	0.00127	CcSEcCtD
Bicalutamide—Oedema—Prednisone—Crohn's disease	0.00097	0.00123	CcSEcCtD
Bicalutamide—Infection—Prednisone—Crohn's disease	0.000964	0.00122	CcSEcCtD
Bicalutamide—Shock—Prednisone—Crohn's disease	0.000955	0.00121	CcSEcCtD
Bicalutamide—Nervous system disorder—Prednisone—Crohn's disease	0.000952	0.0012	CcSEcCtD
Bicalutamide—Skin disorder—Prednisone—Crohn's disease	0.000943	0.00119	CcSEcCtD
Bicalutamide—Hyperhidrosis—Prednisone—Crohn's disease	0.000938	0.00118	CcSEcCtD
Bicalutamide—Anorexia—Prednisone—Crohn's disease	0.000925	0.00117	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000884	0.00112	CcSEcCtD
Bicalutamide—Insomnia—Prednisone—Crohn's disease	0.000878	0.00111	CcSEcCtD
Bicalutamide—Paraesthesia—Prednisone—Crohn's disease	0.000871	0.0011	CcSEcCtD
Bicalutamide—Dyspepsia—Prednisone—Crohn's disease	0.000854	0.00108	CcSEcCtD
Bicalutamide—Decreased appetite—Prednisone—Crohn's disease	0.000844	0.00107	CcSEcCtD
Bicalutamide—Fatigue—Prednisone—Crohn's disease	0.000837	0.00106	CcSEcCtD
Bicalutamide—Constipation—Prednisone—Crohn's disease	0.00083	0.00105	CcSEcCtD
Bicalutamide—Feeling abnormal—Prednisone—Crohn's disease	0.0008	0.00101	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Prednisone—Crohn's disease	0.000794	0.001	CcSEcCtD
Bicalutamide—Urticaria—Prednisone—Crohn's disease	0.000771	0.000973	CcSEcCtD
Bicalutamide—Body temperature increased—Prednisone—Crohn's disease	0.000767	0.000969	CcSEcCtD
Bicalutamide—Abdominal pain—Prednisone—Crohn's disease	0.000767	0.000969	CcSEcCtD
Bicalutamide—Hypersensitivity—Prednisone—Crohn's disease	0.000715	0.000903	CcSEcCtD
Bicalutamide—Asthenia—Prednisone—Crohn's disease	0.000696	0.000879	CcSEcCtD
Bicalutamide—Pruritus—Prednisone—Crohn's disease	0.000687	0.000867	CcSEcCtD
Bicalutamide—Diarrhoea—Prednisone—Crohn's disease	0.000664	0.000838	CcSEcCtD
Bicalutamide—Dizziness—Prednisone—Crohn's disease	0.000642	0.00081	CcSEcCtD
Bicalutamide—Vomiting—Prednisone—Crohn's disease	0.000617	0.000779	CcSEcCtD
Bicalutamide—Rash—Prednisone—Crohn's disease	0.000612	0.000773	CcSEcCtD
Bicalutamide—Dermatitis—Prednisone—Crohn's disease	0.000611	0.000772	CcSEcCtD
Bicalutamide—Headache—Prednisone—Crohn's disease	0.000608	0.000768	CcSEcCtD
Bicalutamide—Nausea—Prednisone—Crohn's disease	0.000576	0.000728	CcSEcCtD
